{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:07:43Z","timestamp":1790856463472,"version":"4.1.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/18\/60\/34181"],"award-info":[{"award-number":["FS\/18\/60\/34181"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical, social and economic burden of cardiovascular disease (CVD) associated with diabetes underscores an urgency for understanding the disease aetiology. Evidence suggests that the hyperglycaemia associated with diabetes is, of itself, causal in the development of endothelial dysfunction (ED) which is recognised to be the critical determinant in the development of CVD. It is further recognised that epigenetic modifications associated with changes in gene expression are causal in both the initiation of ED and the progression to CVD. Understanding whether and how hyperglycaemia induces epigenetic modifications therefore seems crucial in the development of preventative treatments. A mechanistic link between energy metabolism and epigenetic regulation is increasingly becoming explored as key energy metabolites typically serve as substrates or co-factors for epigenetic modifying enzymes. Intriguing examples are the ten-eleven translocation and Jumonji C proteins which facilitate the demethylation of DNA and histones respectively. These are members of the 2-oxoglutarate-dependent dioxygenase superfamily which require the tricarboxylic acid metabolite, \u03b1-ketoglutarate and molecular oxygen (O<jats:sub>2<\/jats:sub>) as substrates and Fe (II) as a co-factor. An understanding of precisely how the biochemical effects of high glucose exposure impact upon cellular metabolism, O<jats:sub>2<\/jats:sub> availability and cellular redox in endothelial cells (ECs) may therefore elucidate (in part) the mechanistic link between hyperglycaemia and epigenetic modifications causal in ED and CVD. It would also provide significant proof of concept that dysregulation of the epigenetic landscape may be causal rather than consequential in the development of pathology.<\/jats:p>","DOI":"10.1186\/s13148-020-00848-y","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T15:03:56Z","timestamp":1588086236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Dysregulation of 2-oxoglutarate-dependent dioxygenases by hyperglycaemia: does this link diabetes and vascular disease?"],"prefix":"10.1186","volume":"12","author":[{"given":"Hannah L. H.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison C.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"issue":"10","key":"848_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrendo.2016.105","volume":"12","author":"P Zimmet","year":"2016","unstructured":"Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616\u201322.","journal-title":"Nat Rev Endocrinol"},{"key":"848_CR2","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"848_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"848_CR4","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/ijms19113665","volume":"19","author":"NA Sallam","year":"2018","unstructured":"Sallam NA, Palmgren VAC, Singh RD, John CM, Thompson JA. Programming of vascular dysfunction in the intrauterine milieu of diabetic pregnancies. Int J Mol Sci. 2018;19(11):3665.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"848_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00592-018-1176-1","volume":"55","author":"N Leybovitz-Haleluya","year":"2018","unstructured":"Leybovitz-Haleluya N, Wainstock T, Landau D, Sheiner E. Maternal gestational diabetes mellitus and the risk of subsequent pediatric cardiovascular diseases of the offspring: a population-based cohort study with up to 18\u2009years of follow up. Acta Diabetol. 2018;55(10):1037\u201342.","journal-title":"Acta Diabetol"},{"issue":"6","key":"848_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajog.2010.02.059","volume":"202","author":"TR Moore","year":"2010","unstructured":"Moore TR. Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am J Obstet Gynecol. 2010;202(6):643\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"848_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"848_CR8","first-page":"383","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N, Jensen GV, Parving HHPO. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. J Cardpulm Rehabil. 2003;348(5):383\u201393.","journal-title":"J Cardpulm Rehabil"},{"issue":"19","key":"848_CR9","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA J Am Med Assoc. 1979;241(19):2035\u20138.","journal-title":"JAMA J Am Med Assoc"},{"issue":"13","key":"848_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIR.0000000000000034","volume":"130","author":"SD De Ferranti","year":"2014","unstructured":"De Ferranti SD, De Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, et al. Type 1 diabetes mellitus and cardiovascular disease a scientific statement from the american heart association andamerican diabetes association. Circulation. 2014;130(13):1110\u201330.","journal-title":"Circulation"},{"issue":"2","key":"848_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"848_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","volume":"9","author":"S Sitia","year":"2010","unstructured":"Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 2010;9(12):830\u20134.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"848_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20050025","volume":"109","author":"CG Schalkwijk","year":"2005","unstructured":"Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci. 2005;109(2):143\u201359.","journal-title":"Clin Sci"},{"issue":"10","key":"848_CR14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840\u20134.","journal-title":"Circ Res"},{"issue":"2","key":"848_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2006.09.016","volume":"193","author":"R Piga","year":"2007","unstructured":"Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis. 2007;193(2):328\u201334.","journal-title":"Atherosclerosis"},{"issue":"3","key":"848_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.yexmp.2017.03.007","volume":"102","author":"CH Yu","year":"2017","unstructured":"Yu CH, Suriguga GM, Liu WJ, Cui NX, Wang Y, et al. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell. Exp Mol Pathol. 2017;102(3):377\u201383.","journal-title":"Exp Mol Pathol"},{"issue":"14","key":"848_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med"},{"issue":"9131","key":"848_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","journal-title":"Lancet"},{"issue":"15","key":"848_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"MA Bethel","year":"2008","unstructured":"Bethel MA, Neil HAW, Paul SK, Matthews DR, Holman RR. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"1","key":"848_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2006.12.025","volume":"196","author":"H Iwasaki","year":"2008","unstructured":"Iwasaki H, Okamoto R, Kato S, Konishi K, Mizutani H, Yamada N, et al. High glucose induces plasminogen activator inhibitor-1 expression through rho\/rho-kinase-mediated NF-\u03baB activation in bovine aortic endothelial cells. Atherosclerosis. 2008;196(1):22\u20138.","journal-title":"Atherosclerosis."},{"issue":"10","key":"848_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00125-004-1525-1","volume":"47","author":"S Srinivasan","year":"2004","unstructured":"Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia. 2004;47(10):1727\u201334.","journal-title":"Diabetologia"},{"issue":"22","key":"848_CR22","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1161\/01.CIR.101.22.2618","volume":"101","author":"FM Ho","year":"2000","unstructured":"Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-JUN NH2-terminal kinase and caspase-3. Circulation. 2000;101(22):2618\u201324.","journal-title":"Circulation"},{"issue":"7","key":"848_CR23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2337\/diab.36.7.808","volume":"36","author":"RL Engerman","year":"1987","unstructured":"Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes. 1987;36(7):808\u201312.","journal-title":"Diabetes"},{"issue":"3","key":"848_CR24","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/diabetes.52.3.818","volume":"52","author":"RA Kowluru","year":"2003","unstructured":"Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818\u201323.","journal-title":"Diabetes"},{"issue":"16","key":"848_CR25","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067\u201372.","journal-title":"Circulation"},{"issue":"4","key":"848_CR26","doi-asserted-by":"publisher","first-page":"10091","DOI":"10.1371\/journal.pone.0010091","volume":"5","author":"V Azcutia","year":"2010","unstructured":"Azcutia V, Abu-Taha M, Romacho T, V\u00e1zquez-Bella M, Matesanz N, Luscinskas FW, et al. Inflammation determines the pro-adhesive properties of high extracellular D-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One. 2010;5(4):10091.","journal-title":"PLoS One"},{"issue":"6","key":"848_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","volume":"5","author":"S Zoungas","year":"2017","unstructured":"Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"848_CR28","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"6865","key":"848_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320.","journal-title":"Nature"},{"issue":"6779","key":"848_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787\u201390.","journal-title":"Nature"},{"issue":"12","key":"848_CR31","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.2337\/db09-1003","volume":"58","author":"C Ling","year":"2009","unstructured":"Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009;58(12):2718\u201325.","journal-title":"Diabetes"},{"issue":"6","key":"848_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/ATVBAHA.119.312193","volume":"39","author":"A Zarzour","year":"2019","unstructured":"Zarzour A, Kim HW, Weintraub NL. Epigenetic regulation of vascular diseases. Arterioscler Thromb Vasc Biol. 2019;39(6):984\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"848_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrendo.2010.188","volume":"6","author":"L Pirola","year":"2010","unstructured":"Pirola L, Balcerczyk A, Okabe J, El-Osta A. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol. 2010;6(12):665\u201375.","journal-title":"Nat Rev Endocrinol."},{"issue":"11","key":"848_CR34","first-page":"1706","volume":"118","author":"J Pasquier","year":"2015","unstructured":"Pasquier J, Hoarau-V\u00e9chot J, Fakhro K, Rafii A, Abi KC. Epigenetics and cardiovascular disease in diabetes. Curr Diab Rep. 2015;118(11):1706\u201322.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"848_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3934\/genet.2019.3.36","volume":"6","author":"SH Othman","year":"2019","unstructured":"Othman SH. The epigenetics of diabetes, obesity, overweight and cardiovascular disease. AIMS Genet. 2019;6(3):36\u201345.","journal-title":"AIMS Genet"},{"issue":"1","key":"848_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/XCE.0000000000000141","volume":"7","author":"G Rodriguez-Araujo","year":"2018","unstructured":"Rodriguez-Araujo G, Nakagami H. Pathophysiology of cardiovascular disease in diabetes mellitus. Cardiovasc Endocrinol Metab. 2018;7(1):4\u20139.","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"848_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fendo.2018.00002","volume":"9","author":"S De Rosa","year":"2018","unstructured":"De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne). 2018;9:2.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"848_CR38","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1101\/gr.116095.110","volume":"21","author":"L Pirola","year":"2011","unstructured":"Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 2011;21(10):1601\u201315.","journal-title":"Genome Res"},{"issue":"2","key":"848_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2013.09.043","volume":"356","author":"C Johnson","year":"2015","unstructured":"Johnson C, Warmoes MO, Shen X, Locasale JW. Epigenetics and cancer metabolism. Cancer Lett. 2015;356(2):309\u201314.","journal-title":"Cancer Lett"},{"issue":"9","key":"848_CR40","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/jcp.24054","volume":"227","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Bultman SJ. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol. 2012;227(9):3169\u201377.","journal-title":"J Cell Physiol"},{"key":"848_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.yjmcc.2019.06.010","volume":"133","author":"MS Stratton","year":"2019","unstructured":"Stratton MS, Farina FM, Elia L. Epigenetics and vascular diseases. J Mol Cell Cardiol. 2019;133:148\u201363.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"848_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247\u201357.","journal-title":"Cell"},{"issue":"6","key":"848_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","volume":"69","author":"E Li","year":"1992","unstructured":"Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69(6):915\u201326.","journal-title":"Cell"},{"key":"848_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fonc.2014.00080","volume":"4","author":"D Subramaniam","year":"2014","unstructured":"Subramaniam D, Thombre R, Dhar A, Anant S. DNA methyltransferases: a novel target for prevention and therapy. Front Oncol. 2014;4:80.","journal-title":"Front Oncol"},{"issue":"5","key":"848_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0960-9822(06)00144-8","volume":"7","author":"Z Siegfried","year":"1997","unstructured":"Siegfried Z, Cedar H. DNA methylation: a molecular lock. Curr Biol. 1997;7(5):305\u20137.","journal-title":"Curr Biol"},{"key":"848_CR46","doi-asserted-by":"crossref","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (80- ). 2009;324(5929):930\u20135.","DOI":"10.1126\/science.1170116"},{"issue":"11","key":"848_CR47","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1093\/hmg\/ddw089","volume":"25","author":"M Sun","year":"2016","unstructured":"Sun M, Song MM, Wei B, Gao Q, Li L, Yao B, et al. 5-Hydroxymethylcytosine-mediated alteration of transposon activity associated with the exposure to adverse in utero environments in human. Hum Mol Genet. 2016;25(11):2208\u201319.","journal-title":"Hum Mol Genet"},{"key":"848_CR48","doi-asserted-by":"crossref","unstructured":"Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science (80- ). 2011;333(6047):1300\u20133.","DOI":"10.1126\/science.1210597"},{"issue":"10","key":"848_CR49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tibs.2013.07.003","volume":"38","author":"CX Song","year":"2013","unstructured":"Song CX, He C. Potential functional roles of DNA demethylation intermediates. Trends Biochem Sci. 2013;38(10):480\u20134.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"848_CR50","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cell.2013.04.001","volume":"153","author":"CX Song","year":"2013","unstructured":"Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell. 2013;153(3):678\u201391.","journal-title":"Cell"},{"issue":"6","key":"848_CR51","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cell.2012.04.027","volume":"149","author":"M Yu","year":"2012","unstructured":"Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, Kim A, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149(6):1368\u201380.","journal-title":"Cell."},{"issue":"5","key":"848_CR52","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2013.02.004","volume":"152","author":"CG Spruijt","year":"2013","unstructured":"Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PWTC, Bauer C, et al. Dynamic readers for 5-(Hydroxy)methylcytosine and its oxidized derivatives. Cell. 2013;152(5):1146\u201359.","journal-title":"Cell"},{"issue":"8","key":"848_CR53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nsmb.2346","volume":"19","author":"MW Kellinger","year":"2012","unstructured":"Kellinger MW, Song CX, Chong J, Lu XY, He C, Wang D. 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat Struct Mol Biol. 2012;19(8):831\u20133.","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"848_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gde.2012.11.006","volume":"23","author":"MR H\u00fcbner","year":"2013","unstructured":"H\u00fcbner MR, Eckersley-Maslin MA, Spector DL. Chromatin organization and transcriptional regulation. Curr Opin Genet Dev. 2013;23(2):89\u201395.","journal-title":"Curr Opin Genet Dev"},{"key":"848_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vph.2018.02.009","volume":"107","author":"GG Schiattarella","year":"2018","unstructured":"Schiattarella GG, Madonna R, Van Linthout S, Thum T, Schulz R, Ferdinandy P, et al. Epigenetic modulation of vascular diseases: assessing the evidence and exploring the opportunities. Vasc Pharmacol. 2018;107:43\u201352.","journal-title":"Vasc Pharmacol"},{"key":"848_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-8935-8-3","volume":"8","author":"N Saksouk","year":"2015","unstructured":"Saksouk N, Simboeck E, D\u00e9jardin J. Constitutive heterochromatin formation and transcription in mammals. Epigenetics and Chromatin. 2015;8:3.","journal-title":"Epigenetics and Chromatin"},{"issue":"3","key":"848_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"},{"issue":"4","key":"848_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/emm.2017.38","volume":"49","author":"HD Youn","year":"2017","unstructured":"Youn HD. Methylation and demethylation of DNA and histones in chromatin: the most complicated epigenetic marker. Exp Mol Med. 2017;49(4):321.","journal-title":"Exp Mol Med"},{"issue":"4","key":"848_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48(4):491\u2013507.","journal-title":"Mol Cell"},{"issue":"49","key":"848_CR60","doi-asserted-by":"publisher","first-page":"35425","DOI":"10.1074\/jbc.R700027200","volume":"282","author":"R Anand","year":"2007","unstructured":"Anand R, Marmorstein R. Structure and mechanism of lysine-specific demethylase enzymes. J Biol Chem. 2007;282(49):35425\u20139.","journal-title":"J Biol Chem"},{"issue":"9","key":"848_CR61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrg1945","volume":"7","author":"RJ Klose","year":"2006","unstructured":"Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006;7(9):715\u201327.","journal-title":"Nat Rev Genet"},{"key":"848_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/HP.S47968","volume":"2","author":"P Pollard","year":"2014","unstructured":"Pollard P, Yang M, Su H, Soga T, Kranc K. Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism. Hypoxia. 2014;2:127\u201342.","journal-title":"Hypoxia"},{"issue":"5","key":"848_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5(5):343\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"848_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1152\/physrev.00041.2017","volume":"99","author":"TP Keeley","year":"2019","unstructured":"Keeley TP, Mann GE. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev. 2019;99(1):161\u2013234.","journal-title":"Physiol Rev"},{"issue":"2","key":"848_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1152\/physiol.00031.2016","volume":"32","author":"L Bierhansl","year":"2017","unstructured":"Bierhansl L, Conradi L-C, Treps L, Dewerchin M, Carmeliet P. Central role of metabolism in endothelial cell function and vascular disease. Physiology. 2017;32(2):126\u201340.","journal-title":"Physiology"},{"key":"848_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2016.08.011","volume":"253","author":"A Pircher","year":"2016","unstructured":"Pircher A, Treps L, Bodrug N, Carmeliet P. Endothelial cell metabolism: a novel player in atherosclerosis? Basic principles and therapeutic opportunities. Atherosclerosis. 2016;253:247\u201357.","journal-title":"Atherosclerosis"},{"issue":"1","key":"848_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/BJ20071249","volume":"409","author":"CT Taylor","year":"2008","unstructured":"Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J. 2008;409(1):19\u201326.","journal-title":"Biochem J"},{"key":"848_CR68","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/rp.56.1.175","volume":"56","author":"RT Watson","year":"2001","unstructured":"Watson RT, Pessin JE. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res. 2001;56:175\u201393.","journal-title":"Recent Prog Horm Res"},{"issue":"8","key":"848_CR69","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2362.2007.01838.x","volume":"37","author":"M Artwohl","year":"2007","unstructured":"Artwohl M, Brunmair B, F\u00fcrnsinn C, H\u00f6lzenbein T, Rainer G, Freudenthaler A, et al. Insulin does not regulate glucose transport and metabolism in human endothelium. Eur J Clin Investig. 2007;37(8):643\u201350.","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"848_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0167-4889(83)90084-8","volume":"762","author":"A Dobrina","year":"1983","unstructured":"Dobrina A, Rossi F. Metabolic properties of freshly isolated bovine endothelial cells. Biochim Biophys Acta. 1983;762(2):295\u2013301.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"848_CR71","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s001250050568","volume":"39","author":"M La Selva","year":"1996","unstructured":"La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia. 1996;39(11):1263\u20138.","journal-title":"Diabetologia"},{"issue":"1","key":"848_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2337\/diabetes.51.1.159","volume":"51","author":"Y Ido","year":"2002","unstructured":"Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells. Diabetes. 2002;51(1):159\u201367.","journal-title":"Diabetes"},{"issue":"7","key":"848_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158619","volume":"11","author":"K Sada","year":"2016","unstructured":"Sada K, Nishikawa T, Kukidome D, Yoshinaga T, Kajihara N, Sonoda K, et al. Hyperglycemia induces cellular hypoxia through production of mitochondrial ROS followed by suppression of aquaporin-1. PLoS One. 2016;11(7):0158619.","journal-title":"PLoS One"},{"issue":"1","key":"848_CR74","doi-asserted-by":"publisher","first-page":"29807","DOI":"10.1371\/journal.pone.0029807","volume":"7","author":"M Bensellam","year":"2012","unstructured":"Bensellam M, Duvilli\u00e9 B, Rybachuk G, Laybutt DR, Magnan C, Guiot Y, et al. Glucose-induced O 2 consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One. 2012;7(1):29807.","journal-title":"PLoS One"},{"issue":"10","key":"848_CR75","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/ars.2016.6755","volume":"26","author":"PA Gerber","year":"2017","unstructured":"Gerber PA, Rutter GA. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxidants Redox Signal. 2017;26(10):501\u201318.","journal-title":"Antioxidants Redox Signal"},{"issue":"11","key":"848_CR76","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.2337\/diabetes.53.11.2931","volume":"53","author":"JR Nyengaard","year":"2004","unstructured":"Nyengaard JR, Ido Y, Kilo C, Williamson JR. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 2004;53(11):2931\u20138.","journal-title":"Diabetes"},{"issue":"1","key":"848_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.prs.0000244830.16906.3f","volume":"119","author":"JM Capla","year":"2007","unstructured":"Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, Ceradini DJ, et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg. 2007;119(1):59\u201370.","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"848_CR78","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acschembio.6b00958","volume":"12","author":"RL Hancock","year":"2017","unstructured":"Hancock RL, Masson N, Dunne K, Flashman E, Kawamura A. The activity of JmjC histone lysine demethylase KDM4A is highly sensitive to oxygen concentrations. ACS Chem Biol. 2017;12(4):1011\u20139.","journal-title":"ACS Chem Biol"},{"issue":"7618","key":"848_CR79","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature19081","volume":"537","author":"B Thienpont","year":"2016","unstructured":"Thienpont B, Steinbacher J, Zhao H, D\u2019Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537(7618):63\u20138.","journal-title":"Nature"},{"issue":"2","key":"848_CR80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/BJ20121155","volume":"449","author":"EM S\u00e1nchez-Fern\u00e1ndez","year":"2013","unstructured":"S\u00e1nchez-Fern\u00e1ndez EM, Tarhonskaya H, Al-Qahtani K, Hopkinson RJ, Mccullagh JSO, Schofield CJ, et al. Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase. Biochem J. 2013;449(2):491\u20136.","journal-title":"Biochem J"},{"issue":"3","key":"848_CR81","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/nar\/gkx1197","volume":"46","author":"S Burr","year":"2018","unstructured":"Burr S, Caldwell A, Chong M, Beretta M, Metcalf S, Hancock M, et al. Oxygen gradients can determine epigenetic asymmetry and cellular differentiation viadifferential regulation of Tet activity in embryonic stem cells. Nucleic Acids Res. 2018;46(3):1210\u201326.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"848_CR82","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1038\/s41598-017-11658-3","volume":"7","author":"G Dobrynin","year":"2017","unstructured":"Dobrynin G, McAllister TE, Leszczynska KB, Ramachandran S, Krieg AJ, Kawamura A, et al. KDM4A regulates HIF-1 levels through H3K9me3. Sci Rep. 2017;7(1):11094.","journal-title":"Sci Rep"},{"key":"848_CR83","doi-asserted-by":"crossref","unstructured":"Batie M, Frost J, Frost M, Wilson JW, Schofield P, Rocha S. Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science (80- ). 2019;363(6432):1222\u20136.","DOI":"10.1126\/science.aau5870"},{"issue":"1","key":"848_CR84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cellsig.2011.08.019","volume":"24","author":"A Melvin","year":"2012","unstructured":"Melvin A, Rocha S. Chromatin as an oxygen sensor and active player in the hypoxia response. Cell Signal. 2012;24(1):35\u201343.","journal-title":"Cell Signal"},{"issue":"12","key":"848_CR85","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s13059-014-0513-0","volume":"15","author":"YP Tsai","year":"2014","unstructured":"Tsai YP, Chen HF, Chen SY, Cheng WC, Wang HW, Shen ZJ, et al. TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator. Genome Biol. 2014;15(12):513.","journal-title":"Genome Biol"},{"issue":"60","key":"848_CR86","first-page":"5092","volume":"48","author":"C Muecke","year":"2016","unstructured":"Muecke C, Dabral S, Seeger W, Pullamsetti SS. Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension. Eur Respir J. 2016;48(60):5092.","journal-title":"Eur Respir J"},{"issue":"1","key":"848_CR87","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1128\/MCB.00444-09","volume":"30","author":"AJ Krieg","year":"2010","unstructured":"Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, Giaccia AJ. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 enhances hypoxic gene expression and tumor growth. Mol Cell Biol. 2010;30(1):344\u201353.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"848_CR88","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/cr.2014.81","volume":"24","author":"H Yang","year":"2014","unstructured":"Yang H, Lin H, Xu H, Zhang L, Cheng L, Wen B, et al. TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites. Cell Res. 2014;24(8):1017\u201320.","journal-title":"Cell Res"},{"issue":"12","key":"848_CR89","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26(12):1326\u201338.","journal-title":"Genes Dev"},{"issue":"6","key":"848_CR90","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/cr500470n","volume":"115","author":"X Lu","year":"2015","unstructured":"Lu X, Zhao BS, He C. TET family proteins: oxidation activity, interacting molecules, and functions in diseases. Chem Rev. 2015;115(6):2225\u201339.","journal-title":"Chem Rev"},{"issue":"1","key":"848_CR91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2353\/ajpath.2009.080650","volume":"174","author":"F Addabbo","year":"2009","unstructured":"Addabbo F, Ratliff B, Park HC, Kuo MC, Ungvari Z, Ciszar A, et al. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Am J Pathol. 2009;174(1):34\u201343.","journal-title":"Am J Pathol"},{"issue":"6","key":"848_CR92","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00424-012-1156-1","volume":"464","author":"A Koziel","year":"2012","unstructured":"Koziel A, Woyda-Ploszczyca A, Kicinska A, Jarmuszkiewicz W. The influence of high glucose on the aerobic metabolism of endothelial EA.hy926 cells. Pflugers Arch Eur J Physiol. 2012;464(6):657\u201369.","journal-title":"Pflugers Arch Eur J Physiol"},{"issue":"8","key":"848_CR93","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.2337\/diabetes.51.8.2496","volume":"51","author":"C Alarcon","year":"2002","unstructured":"Alarcon C, Wicksteed B, Prentki M, Corkey BE, Rhodes CJ. Succinate is a preferential metabolic stimulus-coupling signal for glucose-induced proinsulin biosynthesis translation. Diabetes. 2002;51(8):2496\u2013504.","journal-title":"Diabetes"},{"issue":"1","key":"848_CR94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19(1):17\u201330.","journal-title":"Cancer Cell"},{"issue":"5","key":"848_CR95","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/embor.2011.43","volume":"12","author":"R Chowdhury","year":"2011","unstructured":"Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 2011;12(5):463\u20139.","journal-title":"EMBO Rep"},{"issue":"7390","key":"848_CR96","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature10898","volume":"483","author":"P Koivunen","year":"2012","unstructured":"Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature. 2012;483(7390):484\u20138.","journal-title":"Nature"},{"issue":"7390","key":"848_CR97","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature. 2012;483(7390):474\u20138.","journal-title":"Nature"},{"issue":"2","key":"848_CR98","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nchembio.1141","volume":"9","author":"CL Linster","year":"2013","unstructured":"Linster CL, Van Schaftingen E, Hanson AD. Metabolite damage and its repair or pre-emption. Nat Chem Biol. 2013;9(2):72\u201380.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"848_CR99","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting \u03b1-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010;17(3):225\u201334.","journal-title":"Cancer Cell"},{"issue":"2","key":"848_CR100","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer AM, DeMatteo RG, Venneti S, Finley LWS, Lu C, Judkins AR, et al. Hypoxia induces production of L-2-hydroxyglutarate. Cell Metab. 2015;22(2):304\u201311.","journal-title":"Cell Metab"},{"issue":"9","key":"848_CR101","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1021\/acschembio.6b00290","volume":"11","author":"X Teng","year":"2016","unstructured":"Teng X, Emmett MJ, Lazar MA, Goldberg E, Rabinowitz JD. Lactate dehydrogenase C produces S-2-hydroxyglutarate in mouse testis. ACS Chem Biol. 2016;11(9):2420\u20137.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"848_CR102","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bbcan.2019.01.003","volume":"1871","author":"RJ Gillies","year":"2019","unstructured":"Gillies RJ, Pilot C, Marunaka Y, Fais S. Targeting acidity in cancer and diabetes. Biochim Biophys Acta - Rev Cancer. 2019;1871(2):273\u201380.","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"issue":"2","key":"848_CR103","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmet.2015.06.021","volume":"22","author":"WM Oldham","year":"2015","unstructured":"Oldham WM, Clish CB, Yang Y, Loscalzo J. Hypoxia-mediated increases in l-2-hydroxyglutarate coordinate the metabolic response to reductive stress. Cell Metab. 2015;22(2):291\u2013303.","journal-title":"Cell Metab"},{"issue":"3","key":"848_CR104","doi-asserted-by":"publisher","first-page":"33418","DOI":"10.1371\/journal.pone.0033418","volume":"7","author":"P Sonveaux","year":"2012","unstructured":"Sonveaux P, Copetti T, de Saedeleer CJ, V\u00e9gran F, Verrax J, Kennedy KM, et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One. 2012;7(3):33418.","journal-title":"PLoS One"},{"issue":"28","key":"848_CR105","doi-asserted-by":"publisher","first-page":"10396","DOI":"10.1021\/ja4028346","volume":"135","author":"R Yin","year":"2013","unstructured":"Yin R, Mao SQ, Zhao B, Chong Z, Yang Y, Zhao C, et al. Ascorbic acid enhances tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc. 2013;135(28):10396\u2013403.","journal-title":"J Am Chem Soc"},{"issue":"19","key":"848_CR106","doi-asserted-by":"publisher","first-page":"13669","DOI":"10.1074\/jbc.C113.464800","volume":"288","author":"EA Minor","year":"2013","unstructured":"Minor EA, Court BL, Young JI, Wang G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem. 2013;288(19):13669\u201374.","journal-title":"J Biol Chem"},{"key":"848_CR107","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13072-017-0143-3","volume":"10","author":"KT Ebata","year":"2017","unstructured":"Ebata KT, Mesh K, Liu S, Bilenky M, Fekete A, Acker MG, et al. Vitamin C induces specific demethylation of H3K9me2 in mouse embryonic stem cells via Kdm3a\/b. Epigenetics and Chromatin. 2017;10:36.","journal-title":"Epigenetics and Chromatin."},{"issue":"7100","key":"848_CR108","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nature04853","volume":"442","author":"RJ Klose","year":"2006","unstructured":"Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature. 2006;442(7100):312\u20136.","journal-title":"Nature"},{"issue":"7078","key":"848_CR109","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature04433","volume":"439","author":"YI Tsukada","year":"2006","unstructured":"Tsukada YI, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439(7078):811\u20136.","journal-title":"Nature"},{"key":"848_CR110","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.freeradbiomed.2018.12.009","volume":"131","author":"N Lamadema","year":"2019","unstructured":"Lamadema N, Burr S, Brewer AC. Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox. Free Radic Biol Med. 2019;131:282\u201398.","journal-title":"Free Radic Biol Med"},{"key":"848_CR111","first-page":"282","volume":"131","author":"CA Meza","year":"2019","unstructured":"Meza CA, La Favor JD, Kim DH, Hickner RC. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? Int J Mol Sci. 2019;131:282\u201398.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"848_CR112","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00394-016-1212-2","volume":"55","author":"GB Stefano","year":"2016","unstructured":"Stefano GB, Challenger S, Kream RM. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr. 2016;55(8):2339\u201345.","journal-title":"Eur J Nutr"},{"issue":"14","key":"848_CR113","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","volume":"105","author":"TJ Guzik","year":"2002","unstructured":"Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656\u201362.","journal-title":"Circulation"},{"key":"848_CR114","doi-asserted-by":"publisher","first-page":"31835","DOI":"10.1074\/jbc.M702481200","volume":"282","author":"C Miele","year":"2007","unstructured":"Miele C, Paturzo F, Teperino R, Sakane F, Fiory F, Oriente F, et al. Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization. J Biol Chem. 2007;282:31835\u201343.","journal-title":"J Biol Chem"},{"issue":"6","key":"848_CR115","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/ATVBAHA.107.160754","volume":"28","author":"N Sasaki","year":"2008","unstructured":"Sasaki N, Yamashita T, Takaya T, Shinohara M, Shiraki R, Takeda M, et al. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler Thromb Vasc Biol. 2008;28(6):1068\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"848_CR116","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/1071576031000107344","volume":"37","author":"S Matsumoto","year":"2003","unstructured":"Matsumoto S, Koshiishi I, Inoguchi T, Nawata H, Utsumi H. Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res. 2003;37(7):767\u201372.","journal-title":"Free Radic Res"},{"issue":"6","key":"848_CR117","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597\u2013605.","journal-title":"Circulation"},{"key":"848_CR118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2015.01.028","volume":"82","author":"Y Niu","year":"2015","unstructured":"Niu Y, Desmarais TL, Tong Z, Yao Y, Costa M. Oxidative stress alters global histone modification and DNA methylation. Free Radic Biol Med. 2015;82:22\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"848_CR119","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00417-017-3594-0","volume":"255","author":"RA Kowluru","year":"2017","unstructured":"Kowluru RA, Shan Y. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(5):955\u201362.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"848_CR120","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/emboj.2011.105","volume":"30","author":"C Kumar","year":"2011","unstructured":"Kumar C, Igbaria A, D\u2019Autreaux B, Planson AG, Junot C, Godat E, et al. Glutathione revisited: a vital function in iron metabolism and ancillary role in thiol-redox control. EMBO J. 2011;30(10):2044\u201356.","journal-title":"EMBO J"},{"key":"848_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/BCI.S36141","volume":"9","author":"H Zheng","year":"2016","unstructured":"Zheng H, Wu J, Jin Z, Yan L-J. Protein modifications as manifestations of hyperglycemic glucotoxicity in diabetes and its complications. Biochem Insights. 2016;9:1\u20139.","journal-title":"Biochem Insights"},{"issue":"21","key":"848_CR122","doi-asserted-by":"publisher","first-page":"15506","DOI":"10.1074\/jbc.M608361200","volume":"282","author":"V Montecinos","year":"2007","unstructured":"Montecinos V, Guzm\u00e1n P, Barra V, Villagr\u00e1n M, Mu\u00f1oz-Montesino C, Sotomayor K, et al. Vitamin C is an essential antioxidant that enhances survival of oxidatively stressed human vascular endothelial cells in the presence of a vast molar excess of glutathione. J Biol Chem. 2007;282(21):15506\u201315.","journal-title":"J Biol Chem"},{"key":"848_CR123","doi-asserted-by":"publisher","first-page":"29750","DOI":"10.7554\/eLife.29750","volume":"6","author":"V Camarena","year":"2017","unstructured":"Camarena V, Sant DW, Huff TC, Mustafi S, Muir RK, Aron AT, et al. CAMP signaling regulates DNA hydroxymethylation by augmenting the intracellular labile ferrous iron pool. Elife. 2017;6:29750.","journal-title":"Elife"},{"issue":"5","key":"848_CR124","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1096\/fj.201601116R","volume":"31","author":"DK Deb","year":"2017","unstructured":"Deb DK, Bao R, Li YC. Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney. FASEB J. 2017;31(5):2065\u201375.","journal-title":"FASEB J"},{"issue":"7569","key":"848_CR125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525(7569):389\u201393.","journal-title":"Nature"},{"key":"848_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature09934","volume":"473","author":"H Wu","year":"2011","unstructured":"Wu H, D\u2019Alessio AC, Ito S, Xia K, Wang Z, Cui K, et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature. 2011;473:389\u201393.","journal-title":"Nature"},{"issue":"5","key":"848_CR127","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/emboj.2012.357","volume":"32","author":"R Deplus","year":"2013","unstructured":"Deplus R, Delatte B, Schwinn MK, Defrance M, M\u00e9ndez J, Murphy N, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS. EMBO J. 2013;32(5):645\u201355.","journal-title":"EMBO J"},{"issue":"29","key":"848_CR128","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1074\/jbc.M113.460386","volume":"288","author":"FT Shi","year":"2013","unstructured":"Shi FT, Kim H, Lu W, He Q, Liu D, Goodell MA, et al. Ten-eleven translocation 1 (Tet1) is regulated by o-linked n-acetylglucosamine transferase (ogt) for target gene repression in mouse embryonic stem cells. J Biol Chem. 2013;288(29):20776\u201384.","journal-title":"J Biol Chem"},{"issue":"7433","key":"848_CR129","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature11742","volume":"493","author":"Q Chen","year":"2013","unstructured":"Chen Q, Chen Y, Bian C, Fujiki R, Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature. 2013;493(7433):561\u20134.","journal-title":"Nature."},{"issue":"4","key":"848_CR130","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/leu.2016.268","volume":"31","author":"N Hasegawa","year":"2017","unstructured":"Hasegawa N, Oshima M, Sashida G, Matsui H, Koide S, Saraya A, et al. Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome. Leukemia. 2017;31(4):861\u201371.","journal-title":"Leukemia"},{"issue":"8","key":"848_CR131","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/gb-2013-14-8-r91","volume":"14","author":"F Neri","year":"2013","unstructured":"Neri F, Incarnato D, Krepelova A, Rapelli S, Pagnani A, Zecchina R, et al. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 2013;14(8):91.","journal-title":"Genome Biol"},{"issue":"4","key":"848_CR132","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.molcel.2012.12.019","volume":"49","author":"P Vella","year":"2013","unstructured":"Vella P, Scelfo A, Jammula SG, Chiacchiera F, Williams K, Cuomo A, et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell. 2013;49(4):645\u201356.","journal-title":"Mol Cell"},{"issue":"10","key":"848_CR133","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.tem.2008.09.001","volume":"19","author":"T Issad","year":"2008","unstructured":"Issad T, Kuo MS. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol Metab. 2008;19(10):380\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"848_CR134","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/ATVBAHA.107.159533","volume":"28","author":"B Luo","year":"2008","unstructured":"Luo B, Soesanto Y, McClain DA. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28(4):651\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"848_CR135","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1006\/abbi.2001.2331","volume":"389","author":"Y Akimoto","year":"2001","unstructured":"Akimoto Y, Kreppel LK, Hirano H, Hart GW. Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation. Arch Biochem Biophys. 2001;389(2):166\u201375.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"848_CR136","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2337\/db13-1916","volume":"63","author":"N Dhliwayo","year":"2014","unstructured":"Dhliwayo N, Sarras MP, Luczkowski E, Mason SM, Intine RV. Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation. Diabetes. 2014;63(9):3069\u201376.","journal-title":"Diabetes"},{"issue":"10","key":"848_CR137","doi-asserted-by":"publisher","first-page":"46927","DOI":"10.1371\/journal.pone.0046927","volume":"7","author":"F Ciccarone","year":"2012","unstructured":"Ciccarone F, Klinger FG, Catizone A, Calabrese R, Zampieri M, Bacalini MG, et al. Poly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damage-independent roles. PLoS One. 2012;7(10):46927.","journal-title":"PLoS One"},{"issue":"7715","key":"848_CR138","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","volume":"559","author":"D Wu","year":"2018","unstructured":"Wu D, Hu D, Chen H, Shi G, Fetahu IS, Wu F, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559(7715):637\u201341.","journal-title":"Nature"},{"issue":"4","key":"848_CR139","doi-asserted-by":"publisher","first-page":"60549","DOI":"10.1371\/journal.pone.0060549","volume":"8","author":"M Brauchle","year":"2013","unstructured":"Brauchle M, Yao Z, Arora R, Thigale S, Clay I, Inverardi B, et al. Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation. PLoS One. 2013;8(4):60549.","journal-title":"PLoS One"},{"issue":"12","key":"848_CR140","doi-asserted-by":"publisher","first-page":"1002026","DOI":"10.1371\/journal.pbio.1002026","volume":"12","author":"MB Cheng","year":"2014","unstructured":"Cheng MB, Zhang Y, Cao CY, Zhang WL, Zhang Y, Shen YF. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock. PLoS Biol. 2014;12(12):1002026.","journal-title":"PLoS Biol"},{"issue":"6","key":"848_CR141","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncb2228","volume":"13","author":"A Baba","year":"2011","unstructured":"Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y, et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol. 2011;13(6):668\u201375.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"848_CR142","first-page":"341","volume":"3","author":"A Lopez-Candales","year":"2017","unstructured":"Lopez-Candales A, Hern\u00e1ndez Burgos PM, Hernandez-Suarez DF, Harris D. Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome. J Nat Sci. 2017;3(4):341.","journal-title":"J Nat Sci"},{"issue":"10","key":"848_CR143","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/s00125-013-2974-1","volume":"56","author":"D Montero","year":"2013","unstructured":"Montero D, Walther G, P\u00e9rez-Martin A, Vicente-Salar N, Roche E, Vinet A. Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2013;56(10):2122\u201333.","journal-title":"Diabetologia"},{"key":"848_CR144","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fgene.2018.00427","volume":"9","author":"V Miranda-Gon\u00e7alves","year":"2018","unstructured":"Miranda-Gon\u00e7alves V, Lameirinhas A, Henrique R, Jer\u00f3nimo C. Metabolism and epigenetic interplay in cancer: regulation and putative therapeutic targets. Front Genet. 2018;9:427.","journal-title":"Front Genet"},{"key":"848_CR145","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.pharmthera.2018.08.008","volume":"193","author":"A Ferrari","year":"2019","unstructured":"Ferrari A, Longo R, Silva R, Mitro N, Caruso D, De Fabiani E, et al. Epigenome modifiers and metabolic rewiring: new frontiers in therapeutics. Pharmacol Ther. 2019;193:178\u201393.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"848_CR146","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SMC Langemeijer","year":"2009","unstructured":"Langemeijer SMC, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838\u201342.","journal-title":"Nat Genet"},{"issue":"25","key":"848_CR147","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","volume":"113","author":"AM Jankowska","year":"2009","unstructured":"Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms. Blood. 2009;113(25):6403\u201310.","journal-title":"Blood"},{"issue":"29","key":"848_CR148","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1073\/pnas.1310656110","volume":"110","author":"H Huang","year":"2013","unstructured":"Huang H, Jiang X, Li Z, Li Y, Song CX, He C, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(29):11994\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"848_CR149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronn\u00e9","year":"2012","unstructured":"Couronn\u00e9 L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012;366(1):95\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"848_CR150","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3324\/haematol.2013.088740","volume":"98","author":"F Asmar","year":"2013","unstructured":"Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, Nielsen AB, et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica. 2013;98(12):1912\u201320.","journal-title":"Haematologica"},{"issue":"2","key":"848_CR151","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"848_CR152","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2217\/epi.13.79","volume":"6","author":"C Johansson","year":"2014","unstructured":"Johansson C, Tumber A, Che KH, Cain P, Nowak R, Gileadi C, et al. The roles of Jumonji-type oxygenases in human disease. Epigenomics. 2014;6(1):89\u2013120.","journal-title":"Epigenomics"},{"issue":"11","key":"848_CR153","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tcb.2014.08.010","volume":"24","author":"P Bheda","year":"2014","unstructured":"Bheda P, Schneider R. Epigenetics reloaded: the single-cell revolution. Trends Cell Biol. 2014;24(11):712\u201323.","journal-title":"Trends Cell Biol"},{"issue":"17","key":"848_CR154","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1111\/febs.13768","volume":"283","author":"S Vora","year":"2016","unstructured":"Vora S, Tuttle M, Cheng J, Church G. Next stop for the CRISPR revolution: RNA-guided epigenetic regulators. FEBS J. 2016;283(17):3181\u201393.","journal-title":"FEBS J"},{"issue":"20","key":"848_CR155","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/jnci\/dji311","volume":"97","author":"F Lyko","year":"2005","unstructured":"Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005;97(20):1498\u2013506.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"848_CR156","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","volume":"1","author":"JM Wagner","year":"2010","unstructured":"Wagner JM, Hackanson B, Lubbert M, Jung M. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics. 2010;1(3):117\u201336.","journal-title":"Clin Epigenetics"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00848-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00848-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00848-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T23:12:31Z","timestamp":1619565151000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00848-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00848-y","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"17 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Both authors have reviewed the manuscript and given consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}